• Implemented MasterCare+ SaaS across new sites
• Integrating Digital Front Door and ReferralNet Secure Messaging
• Upgrading Lifecard Personal Health Record for consumer engagement
• Reducing workforce by 10% through AI adoption

Global Health Limited (ASX: GLH) released its Appendix 4C Cash Flow Report for the quarter ended 30 September 2025, along with the accompanying Quarterly Business Activity Report. The principal focus during the reporting period was the implementation of the Company's MasterCare+ SaaS across new sites procured prior to July and new sales signed in the September quarter. Five sites went live with MasterCare+ with a further 15 new implementations expected by March 2026. Work also commenced on the integration of the Company's Digital Front Door and ReferralNet Secure Messaging platform to Best Practice and MasterCare EMR, scheduled for completion in the current December quarter. The technology upgrade of the Lifecard Personal Health Record for consumer active engagement in their health and wellness continued through the quarter and is in final QA, with general release expected in the current December quarter. The Company is also continuing the incorporation of MasterCare PAS functionality within the MasterCare Plus composable SaaS platform, with completion due by June 2026. As is typical in the initial months of a new financial year, there were many new sales prospects, with over $400K in signed deals during the quarter, open tenders with a value more than $5M, and a further $2.6M in qualified leads. Internally, the Company has been adopting AI to improve productivity, enabling a 10% reduction in the workforce over the September quarter, with further gains expected as more processes are re-imagined with AI. The closing cash of $439K at the end of September was primarily due to the delay of the R&D refund of $720K, which was received in the first week of October.

The traditional Australian Healthcare segments are expanding beyond primary and acute care with new segments emerging due to increased obligations of employers to support employee psychosocial well-being. Global Health's position as a leading provider to service providers living with Mental Health, other chronic conditions, and Alcohol and Other Drug dependencies places it in a good position to diversify beyond the traditional healthcare provider markets. There is also a strong move to home-based and remote care, which is well-supported by the Company's suite of platforms, especially the Lifecard Personal Health Record, augmented with appropriate AI. Consequently, the Company expects to augment its B2B business with a B2C business model. The considerable investments in technology and platform modernisation are in the final stages, enabling the R&D expense to be reduced by a further 20% from $2.1M in FY2025 to $1.7M in FY2026, with the savings to be redirected to new customer acquisition initiatives and global market expansion.